3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

856

Participants

Timeline

Start Date

January 31, 1996

Conditions
Breast Neoplasms
Interventions
DRUG

Anastrozole

Trial Locations (51)

Unknown

Research Site, Amstetten

Research Site, Bad Ischl

Research Site, Baden

Research Site, Bregenz

Research Site, Bruck an der Mur

Research Site, Dornbirn

Research Site, Eisenstadt

Research Site, Feldbach

Research Site, Feldkirch

Research Site, Freistadt

Research Site, Fürstenfeld

Research Site, Graz

Research Site, Güssing

Research Site, Hainburg an der Donau

Research Site, Hartberg

Research site, Hollabrunn

Research Site, Horn

Research Site, Innsbruck

Research Site, Kirchdorf

Research Site, Klagenfurt

Research Site, Klosterneuburg

Research Site, Krems

Research Site, Kufstein

Research Site, Leoben

Research Site, Linz

Research Site, Mistelbach

Research Site, Mödling

Research Site, Neunkirche

Research Site, Oberpullendorf

Research Site, Oberwart

Research Site, Ried im Innkreis

Research Site, Rohrbach

Research Site, Rottenmann

Research Site, Salzburg

Research Site, Sankt Pölten

Research Site, Sankt Veit an der Glan

Research Site, Schärding

Research Site, Scheibbs

Research Site, Schladming

Research Site, Schwarzach

Research Site, Spittal an der Drau

Research Site, Steyr

Research Site, Tulln

Research Site, Vienna

Research Site, Villach

Research Site, Vöcklabruck

Research Site, Waidhofen an der Ybbs

Research Site, Wels

Research Site, Wiener Neustadt

Research Site, Wolfsberg

Research Site, Zams

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY